Dr Kesinee Chotivanich
Contact information
Podcast interview
Malaria laboratory at MORU
More effective diagnosis and treatments are needed to reduce the morbidity and mortality affecting malaria patients. Researchers at the Malaria Laboratory at MORU study the pathophysiology of the disease, and test new compound drugs for anti-malarial activity. In the context of growing artemisinin resistance, this research will have a global impact
Research groups
Kesinee Chotivanich
Associate professor
Malaria laboratory
The MORU Malaria laboratory, Bangkok, Thailand provides facilities and resources to researchers, students, and collaborators who are interested in tropical diseases. We aim to generate new knowledge in order to improve patients’ care. Major research areas of interest are the pathophysiology of malaria, host-parasite interaction, the pharmacodynamics of antimalarial drugs, the mechanism of antimalarial drug resistance, and the development diagnostic tools. Currently, we have 5 PhD students and 9 scientists working in our laboratory.
Recent publications
-
Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester
Journal article
Harrington WE. et al, (2021), BMC Medicine, 19
-
Returned traveler presenting with anemia: Clinical challenge of post-artesunate delayed hemolysis.
Journal article
Matsee W. et al, (2021), Journal of travel medicine
-
Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage.
Journal article
Kümpornsin K. et al, (2021), International journal for parasitology. Drugs and drug resistance, 17, 186 - 190
-
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
Journal article
Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42
-
Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure.
Journal article
Witmer K. et al, (2020), Antimicrobial agents and chemotherapy, 65